Virtu KCG Holdings’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Virtu KCG Holdings’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$783K	Buy	13,110 +6,863	+110%	+$384K	0.02%	758
2017 Q1	$333K	Buy	6,247 +538	+9%	+$31.9K	0.01%	1818
2016 Q4	$285K	Buy	+5,709	New	+$306K	0.01%	2162
2015 Q3	–	Sell	-13,165	Closed	-$793K	–	4023
2015 Q2	$793K	Buy	+13,165	New	+$870K	0.01%	1066

Other funds holding ONCE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Virtu KCG Holdings's ONCE Position: Q2 2017 in Review

Virtu KCG Holdings increased its Spark Therapeutics, Inc. Common Stock (ONCE) stake by 110% in Q2 2017, buying an estimated $384K and bringing the position to 13,110 shares worth $783K. The position accounts for 0.02% of the portfolio, ranked #758.

Virtu KCG Holdings first reported a position in ONCE in Q2 2015 and has held it in 4 quarters since. The position peaked at $793K in Q2 2015. 127 funds tracked by Wall St. Rank hold ONCE as of Q2 2017.

Virtu KCG Holdings held 13,110 shares of Spark Therapeutics, Inc. Common Stock worth $783K as of Q2 2017.
Virtu KCG Holdings bought 6,863 Spark Therapeutics, Inc. Common Stock shares in Q2 2017, an estimated $384K.
Spark Therapeutics, Inc. Common Stock made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #758 holding.
Virtu KCG Holdings first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and has held it in 4 quarters since.
Virtu KCG Holdings's Spark Therapeutics, Inc. Common Stock position peaked at $793K in Q2 2015.
127 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.